1 | Acetate | [1] Acetate Acetate | - | - | - | [41] 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬 |
2 | ADVATE | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
3 | ADVATE (rAHF - PFM) | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
4 | ADVATE (rAHF-PFM) | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
5 | ADVATE 1000 IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
6 | ADVATE 1000IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
7 | ADVATE 500 IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
8 | Alphanate | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
9 | Alphanate 1000 I.U. | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
10 | Alphanate 1500 I.U. | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
11 | Alphanate SD/HT | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
12 | ALPHANATE*INF 1F 1000UI+F 10ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
13 | ALPHANATE*INF 1F 1500UI+F 10ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
14 | ALPHANATE*INF 1F 250UI+F 5ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
15 | ALPHANATE*INF 1F 500UI+F 5ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
16 | Antihemophilic Factor (Recombinant) | - | - | - | - | [1] 288 288 💬 |
17 | APCC, aPCC + TXA | - | - | - | - | [1] 288 288 💬 |
18 | ARC 1779 | - | - | - | - | [2] 64 64, 288 💬 |
19 | ARC1779 | - | - | - | - | [2] 64 64, 288 💬 |
20 | ARC1779 Injection | - | - | - | - | [2] 64 64, 288 💬 |
21 | BAX 111 | - | - | - | - | [1] 288 288 💬 |
22 | BAX111 | - | - | - | - | [1] 288 288 💬 |
23 | Biostate | - | - | - | - | [1] 288 288 💬 |
24 | Biostate® | - | - | - | - | [1] 288 288 💬 |
25 | BIVV001 (rFVIIIFc-VWF-XTEN) | - | - | - | - | [1] 288 288 💬 |
26 | Blood coagulation Factor VIII and vWF, human | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
27 | Blood sample | - | - | - | - | [20] 8 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 💬 |
28 | BORTEZOMIB | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬 | [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [17] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 |
29 | Catridecacog | [1] Catridecacog Catridecacog | [1] Catridecacog
Catridecacog
💬 | - | - | [2] 97 97, 288 💬 |
30 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [28] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬 |
31 | Cluvot | - | - | - | - | [1] 288 288 💬 |
32 | Coagadex | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
33 | Coagulación factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
34 | Coagulation factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
35 | Coagulation factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
36 | Coagulation factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬 |
37 | CoFactor | - | - | - | - | [2] 265 265, 288 💬 |
38 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬 |
39 | DDAVP | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬 | [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 75 75, 288 💬 |
40 | DDAVP (Desmopressin) | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬 | [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 288 288 💬 |
41 | Desmopressin | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬 | [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [5] 6 6, 64, 72, 225, 288 💬 |
42 | Desmopressin acetate | [2] Acetate Acetate, Desmopressin | [1] Desmopressin
Desmopressin
💬 | [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬 |
43 | Desmopressine | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬 | [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 225 225, 288 💬 |
44 | Efanesoctocog alfa | [1] Efanesoctocog alfa Efanesoctocog alfa | [1] Efanesoctocog alfa
Efanesoctocog alfa
💬 | - | - | [1] 288 288 💬 |
45 | Emicizumab | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬 | [2] F10 F10, F9 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬 |
46 | Emicizumab (ACE910, RO5534262) | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬 | [2] F10 F10, F9 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬 |
47 | Emicizumab Injection | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬 | [2] F10 F10, F9 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬 |
48 | Eqwilate | - | - | - | - | [1] 288 288 💬 |
49 | F13CD | - | - | - | - | [1] 288 288 💬 |
50 | F8VR | - | - | - | - | [1] 288 288 💬 |
51 | FACTANE 200 IU/ml | - | - | - | - | [1] 288 288 💬 |
52 | Factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
53 | Factor VIII concentrate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
54 | Factor von Willebrand | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
55 | FACTOR X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
56 | Factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [3] 51 51, 97, 288 💬 |
57 | Factor XIII Concentrate (Human) | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬 |
58 | Factor XIII Concentrate (Human), Pasteurized | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬 |
59 | Fanhdi | - | - | - | - | [1] 288 288 💬 |
60 | FANHDI 100 UI | - | - | - | - | [1] 288 288 💬 |
61 | Fanhdi 100 UI FVIII-120 UI FVW | - | - | - | - | [1] 288 288 💬 |
62 | FANHDI 25 UI | - | - | - | - | [1] 288 288 💬 |
63 | Fanhdi 25 UI FVIII-30 UI FVW | - | - | - | - | [1] 288 288 💬 |
64 | FANHDI 250UI*1F 250UI+F 10ML | - | - | - | - | [1] 288 288 💬 |
65 | FANHDI 50 UI | - | - | - | - | [1] 288 288 💬 |
66 | Fanhdi 50 UI FVIII-60 UI FVW | - | - | - | - | [1] 288 288 💬 |
67 | FANHDI*INF FL 250UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬 |
68 | FANHDI*INF FL 500UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬 |
69 | FANHDI*INF FL1000UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬 |
70 | FANHDI*INF FL250UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬 |
71 | Fibrogammin P | - | - | - | - | [1] 288 288 💬 |
72 | Fibrogammin® P | - | - | - | - | [1] 288 288 💬 |
73 | Fibrogammin®P | - | - | - | - | [1] 288 288 💬 |
74 | FXIII Concentrate (Human) | - | - | - | - | [1] 288 288 💬 |
75 | FXIII Concentrate (Human) (FXIII) | - | - | - | - | [1] 288 288 💬 |
76 | Haemate P | - | - | - | - | [1] 288 288 💬 |
77 | Haemate P® (Human Coagulation Factor VIII) | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬 |
78 | Haemate-P, Wilate | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
79 | Haemate® P 250 | - | - | - | - | [1] 288 288 💬 |
80 | Hemlibra | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬 | [2] F10 F10, F9 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬 |
81 | Hemlibra® | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬 | [2] F10 F10, F9 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬 |
82 | HEMOFIX | - | - | - | - | [1] 288 288 💬 |
83 | HUMAN COAGULATION FACTOR VIII | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬 |
84 | Human coagulation Factor VIII / von Willebrand Factor | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
85 | Human coagulation factor VIII associated with Von Willebrand factor (VWF) | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
86 | Human Coagulation Factor VIII, Von Willebrand Factor | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
87 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
88 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬 |
89 | Human Coagulation FACTOR X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
90 | Human factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬 |
91 | HUMAN VON WILLEBRAND FACTOR | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
92 | Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII) | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
93 | Human VWF/FVIII concentrate | - | - | - | - | [1] 288 288 💬 |
94 | Humate-P | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
95 | IL-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬 |
96 | Interleukin 11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬 |
97 | Interleukin-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [2] 96 96, 288 💬 |
98 | Marketed plasma-derived VWF/FVIII concentrate | - | - | - | - | [1] 288 288 💬 |
99 | Minirin | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬 | [2] AVPR2 AVPR2, F8 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬 |
100 | Minrin | - | - | - | - | [1] 288 288 💬 |
101 | Natriumchlorid | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 288 288 💬 |
102 | Natriumchlorid 0,9 % | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [1] 288 288 💬 |
103 | Neumega (Oprelvekin, Interleukin 11, IL-11) | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬 |
104 | NN 1841 | - | - | - | - | [1] 288 288 💬 |
105 | NN1841 | - | - | - | - | [1] 288 288 💬 |
106 | OBI-1 | - | - | - | - | [1] 288 288 💬 |
107 | OBIZUR | [1] Susoctocog alfa Susoctocog alfa | [1] Susoctocog alfa
Susoctocog alfa
💬 | - | - | [1] 288 288 💬 |
108 | Obyoctocog alfa | - | - | - | - | [1] 288 288 💬 |
109 | Octanate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
110 | OCTANATE 100 UI/ml, poudre et solvant pour solution injectable | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
111 | OCTANATE 50 UI/ml, poudre et solvant pour solution injectable | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
112 | OCTOCOG ALFA | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
113 | Octostim | - | - | - | - | [2] 64 64, 288 💬 |
114 | Oprelvekin | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬 |
115 | Oprelvekin, Interleukin 11, IL-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬 |
116 | Optivate | - | - | - | - | [1] 288 288 💬 |
117 | Optivate® (Human Coagulation Factor VIII) | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬 |
118 | Physiologische Kochsalzlösung Fresenius - Infusionslösung | - | - | - | - | [1] 288 288 💬 |
119 | Phytomenadione | [1] Phylloquinone Phylloquinone | - | - | - | [1] 288 288 💬 |
120 | Plasma-derived FVIII/VWF concentrate | - | - | - | - | [1] 288 288 💬 |
121 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
122 | Prothrombin | [1] Prothrombin Prothrombin | - | - | - | [1] 288 288 💬 |
123 | Prothrombin Complex Concentrate | [2] Factor IX Complex (Human) Factor IX Complex (Human), Prothrombin | - | - | - | [1] 288 288 💬 |
124 | RAHF | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬 |
125 | Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
126 | Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
127 | Recombinant factor VIIII (rFVIII) | - | - | - | - | [1] 288 288 💬 |
128 | Recombinant Factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬 |
129 | Recombinant Factor XIII (rFXIII) | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [2] 97 97, 288 💬 |
130 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬 |
131 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
132 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
133 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
134 | Recombinant human von Willebrand Factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
135 | Recombinant interleukin-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬 | [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬 |
136 | Recombinant porcine coagulation factor VIII (B domain deleted) | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
137 | Recombinant porcine coagulation factor VIII (B-domain deleted) | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
138 | Recombinant von Willebrand Factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
139 | Recombinant von Willebrand Factor (rVWF) | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
140 | Recombinant von Willebrand Factor 1300IU | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
141 | Recombinant von Willebrand Factor 650IU | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
142 | Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII) | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
143 | Recomibnant human Von Willebrand Factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
144 | RFVIIa | [1] Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | - | - | - | [1] 288 288 💬 |
145 | RFVIIa, rFVIIa + TXA | [1] Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | - | - | - | [1] 288 288 💬 |
146 | RFVIII | - | - | - | - | [1] 288 288 💬 |
147 | Rituxan | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 46 46, 60, 256, 288 💬 |
148 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
149 | RO5534262 EMICIZUMAB | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬 | [2] F10 F10, F9 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬 |
150 | Rurioctocog alfa pegol | [1] Rurioctocog alfa pegol Rurioctocog alfa pegol | [1] Rurioctocog alfa pegol
Rurioctocog alfa pegol
💬 | - | - | [1] 288 288 💬 |
151 | RVWF | - | - | - | - | [1] 288 288 💬 |
152 | Saline solution | - | - | - | - | [4] 2 2, 34, 288, 299 💬 |
153 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
154 | Simvastatine | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬 | [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 6 6, 13, 288 💬 |
155 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [20] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
156 | SODIUM CHLORIDE SOLUTION 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [4] 51 51, 60, 288, 299 💬 |
157 | Standard of Care for Haemophilia A | - | - | - | - | [1] 288 288 💬 |
158 | Standard of Care FVIII Replacement therapy | - | - | - | - | [1] 288 288 💬 |
159 | Steroid | - | - | - | - | [2] 107 107, 288 💬 |
160 | TAK-672 | - | - | - | - | [1] 288 288 💬 |
161 | Tranexamic acid | [1] Tranexamic acid Tranexamic acid | [1] Tranexamic acid
Tranexamic acid
💬 | [1] PLG PLG 💬 | [4] Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | [7] 46 46, 70, 215, 227, 274, 288, 299 💬 |
162 | VEYONDI 650IU powder and solvent for solution for injection | - | - | - | - | [1] 288 288 💬 |
163 | Veyvondi | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬 | - | - | [1] 288 288 💬 |
164 | VEYVONDI 1300 IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬 | - | - | [1] 288 288 💬 |
165 | VEYVONDI 1300I IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬 | - | - | [1] 288 288 💬 |
166 | VEYVONDI 1300IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬 | - | - | [1] 288 288 💬 |
167 | VEYVONDI 650IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬 | - | - | [1] 288 288 💬 |
168 | Von willebrand factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [2] 64 64, 288 💬 |
169 | Von Willebrand factor (Recombinant) | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
170 | Von Willebrand factor and coagulation factor VIII in combination | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
171 | Von Willebrand Factor Antigen | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
172 | Von Willebrand Factor Ristocetin Cofactor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
173 | Von Willebrand Faktor | - | - | - | - | [1] 288 288 💬 |
174 | Voncento | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
175 | Voncento, Biostate® | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
176 | Voncento® | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
177 | VONICOG ALFA | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬 | - | - | [1] 288 288 💬 |
178 | VWD factor VIII concentrate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬 |
179 | VWF gene analysis | - | - | - | - | [1] 288 288 💬 |
180 | VWF replacement therapy with Wilate | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
181 | VWF SD-35-DH | - | - | - | - | [1] 288 288 💬 |
182 | VWF-containing products | - | - | - | - | [1] 288 288 💬 |
183 | VWF/FVIII products | - | - | - | - | [1] 288 288 💬 |
184 | WILATE | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
185 | Wilate 1000 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
186 | WILATE 1000 I.U. | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
187 | WILATE 450 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
188 | Wilate 500 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
189 | WILATE 500 I.U. | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
190 | WILATE 900 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
191 | WILATE® 450 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬 |
192 | WILFACTIN | - | - | - | - | [1] 288 288 💬 |
193 | Willfact | - | - | - | - | [1] 288 288 💬 |
194 | Wiloctin | - | - | - | - | [1] 288 288 💬 |